CoChat

Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease

Open access
Reyes, Juan F., Ekmark-Léwen, Sara, Perdiki, Marina, Klingstedt, Therése, Hoffmann, Alana, Wiechec, Emilia, Nilsson, Per, Nilsson, K. Peter R., Alafuzoff, Irina, Ingelsson, Martin, Hallbeck, Martin · 2021 · Acta Neuropathologica Communications

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Abstract

Alpha-synuclein (α-syn) aggregation is the hallmark pathological lesion in brains of patients with Parkinson’s disease (PD) and related neurological disorders characterized as synucleinopathies. Accumulating evidence now indicates that α-syn deposition is also present within the gut and other peripheral organs outside the central nervous system (CNS). In the current study, we demonstrate for the first time that α-syn pathology also accumulates within the liver, the main organ responsible for substance clearance and detoxification. We further demonstrate that cultured human hepatocytes readily internalize oligomeric α-syn assemblies mediated, at least in part, by the gap junction protein connexin-32 (Cx32). Moreover, we identified a time-dependent accumulation of α-syn within the liver of three different transgenic (tg) mouse models expressing human α-syn under CNS-specific promoters, despite the lack of α-syn mRNA expression within the liver. Such a brain-to-liver transmission route could be further corroborated by detection of α-syn pathology within the liver of wild type mice one month after a single striatal α-syn injection. In contrast to the synucleinopathy models, aged mice modeling AD rarely show any amyloid-beta (Aß) deposition within the liver. In human post-mortem liver tissue, we identified cases with neuropathologically confirmed α-syn pathology containing α-syn within hepatocellular structures to a higher degree (75%) than control subjects without α-syn accumulation in the brain (57%). Our results reveal that α-syn accumulates within the liver and may be derived from the brain or other peripheral sources. Collectively, our findings indicate that the liver may play a role in the clearance and detoxification of pathological proteins in PD and related synucleinopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40478-021-01136-3

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Human hepatocytes take up oligomeric α-syn assemblies in vitro. A Characterization of oligomeric and fibrillar α-syn-ATTO-550 assemblies using electron microscopy. B Western blot quantification of oligomeric and fibrillar α-syn uptake in primary human hepatocytes. C–F Immunocytochemistry of primary hepatocytes showing the internalization of α-syn-ATTO-550 labeled oligomers immunolabeled with the human specific α-syn antibody 14H (arrow head). G, H Immunocytochemistry of primary hepatocytes showing a partial co-localization between α-syn-ATTO-550 oligomers and the gap junction protein Cx32 (asterisk). K–N HuH-7 cells labeled with ß-tubulin (gray) expressing Cx32-mCherry (red) co-localize with α-syn-ATTO-488 oligomers (green, arrow head). All cells were counterstained with DAPI (blue). Bars = 20 µm. Statistical analysis was performed using one-way ANOVA with n = 3 using a Tukey's multiple comparison test, *p < 0.05
Fig. 1 Human hepatocytes take up oligomeric α-syn assemblies in vitro. A Characterization of oligomeric and fibrillar α-syn-ATTO-550 assemblies using electron microscopy. B Western blot quantification of oligomeric and fibrillar α-syn uptake in primary human hepatocytes. C–F Immunocytochemistry of primary hepatocytes showing the internalization of α-syn-ATTO-550 labeled oligomers immunolabeled with the human specific α-syn antibody 14H (arrow head). G, H Immunocytochemistry of primary hepatocytes showing a partial co-localization between α-syn-ATTO-550 oligomers and the gap junction protein Cx32 (asterisk). K–N HuH-7 cells labeled with ß-tubulin (gray) expressing Cx32-mCherry (red) co-localize with α-syn-ATTO-488 oligomers (green, arrow head). All cells were counterstained with DAPI (blue). Bars = 20 µm. Statistical analysis was performed using one-way ANOVA with n = 3 using a Tukey's multiple comparison test, *p < 0.05CC BY · PubMed Central
Fig. 2 Age dependent accumulation of human α-syn deposits within the liver of the A30P transgenic mouse model. A–C Identification of human α-syn deposits (red) in young (3 months) liver tissue sections of the A30P mice located within the portal tracts and D–F, rosette-like structures within the liver parenchyma. Insert within panel A shows the deposition of α-syn at 3 months of age immune-stained with pS129 antibodies (green). G–I Aged A30P liver tissue sections (18 months) showing the progressive accumulation of α-syn deposits within the portal tracts and J–L, liver parenchyma. Insert within panel G shows the deposition of α-syn at 18 months of age immune-stained with pS129 antibodies (green). All liver tissue sections were counterstained with DAPI (blue). Bars = 20 µm
Fig. 2 Age dependent accumulation of human α-syn deposits within the liver of the A30P transgenic mouse model. A–C Identification of human α-syn deposits (red) in young (3 months) liver tissue sections of the A30P mice located within the portal tracts and D–F, rosette-like structures within the liver parenchyma. Insert within panel A shows the deposition of α-syn at 3 months of age immune-stained with pS129 antibodies (green). G–I Aged A30P liver tissue sections (18 months) showing the progressive accumulation of α-syn deposits within the portal tracts and J–L, liver parenchyma. Insert within panel G shows the deposition of α-syn at 18 months of age immune-stained with pS129 antibodies (green). All liver tissue sections were counterstained with DAPI (blue). Bars = 20 µmCC BY · PubMed Central
Fig. 3 Human α-syn deposits within the A30P mouse liver are selectively phosphorylated at serine 129 (pS129). A–H Human α-syn deposits within the transgenic A30P mouse liver immunolabeled with the 14H antibody co-localize with the human specific 211 α-syn antibody. I–P Human α-syn deposits within the A30P liver are partially phosphorylated at serine 129. All tissue sections were counterstained with DAPI (blue). Bars = 20 µm
Fig. 3 Human α-syn deposits within the A30P mouse liver are selectively phosphorylated at serine 129 (pS129). A–H Human α-syn deposits within the transgenic A30P mouse liver immunolabeled with the 14H antibody co-localize with the human specific 211 α-syn antibody. I–P Human α-syn deposits within the A30P liver are partially phosphorylated at serine 129. All tissue sections were counterstained with DAPI (blue). Bars = 20 µmCC BY · PubMed Central
Fig. 4 Human α-syn inclusions within the mouse A30P liver co-localize with luminescent conjugated oligothiophenes (LCOs). A–D Human α-syn deposits immunolabeled with the 14H antibody partially co-localize with the p-FTAA and E–H HS-68 LCOs in aged A30P livers. All tissue sections were counterstained with Hoechst (blue). I Individual and J average emission spectra obtained from HS-68-positive human α-syn deposits in the aged A30P liver. K Average emission spectra obtained from HS-68-positive α-syn aggregates from human PD brains (n = 3, blue) and human MSA brains (n = 3, red). Note that the spectra in the human brains were obtained using a filter which cuts off the emitted light at 625 nm in wavelength, which was not used for this study. K Adapted from [37] with permission. © The Author(s). 2019 Open Access. Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). Bars = 20 µm
Fig. 4 Human α-syn inclusions within the mouse A30P liver co-localize with luminescent conjugated oligothiophenes (LCOs). A–D Human α-syn deposits immunolabeled with the 14H antibody partially co-localize with the p-FTAA and E–H HS-68 LCOs in aged A30P livers. All tissue sections were counterstained with Hoechst (blue). I Individual and J average emission spectra obtained from HS-68-positive human α-syn deposits in the aged A30P liver. K Average emission spectra obtained from HS-68-positive α-syn aggregates from human PD brains (n = 3, blue) and human MSA brains (n = 3, red). Note that the spectra in the human brains were obtained using a filter which cuts off the emitted light at 625 nm in wavelength, which was not used for this study. K Adapted from [37] with permission. © The Author(s). 2019 Open Access. Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). Bars = 20 µmCC BY · PubMed Central
Fig. 5 Alpha-synuclein is transported from the brain to the liver following a single striatal injection of mouse α-syn (mα-syn) oligomers. B–D, F–H mα-syn oligomers are detected within the portal tracts of the wild type mice 1-month post striatal injection. A, E Adjacent tissue sections lacking primary antibody (1°delete) show no mα-syn immunoreactivity. I–L Injected mα-syn oligomers detected within the portal tracts or M–P liver parenchyma are not phosphorylated at serine 129 (pS129) 1-month post injection. All tissue sections were counterstained with DAPI (blue). Bars = 20 µm
Fig. 5 Alpha-synuclein is transported from the brain to the liver following a single striatal injection of mouse α-syn (mα-syn) oligomers. B–D, F–H mα-syn oligomers are detected within the portal tracts of the wild type mice 1-month post striatal injection. A, E Adjacent tissue sections lacking primary antibody (1°delete) show no mα-syn immunoreactivity. I–L Injected mα-syn oligomers detected within the portal tracts or M–P liver parenchyma are not phosphorylated at serine 129 (pS129) 1-month post injection. All tissue sections were counterstained with DAPI (blue). Bars = 20 µmCC BY · PubMed Central
Fig. 6 The A30P mouse model of PD shows a progressive inflammation within the liver. A, B Hematoxylin and Eosin (H&E) staining shows no detectable inflammation within the liver in young (3 months) or E, F aged (18 months) wild type mice. C, D H&E staining within the young A30P liver shows focal inflammation within the liver parenchyma that is progressive and much more prominent in the aged A30P liver (G, H). Bars = 20 µm
Fig. 6 The A30P mouse model of PD shows a progressive inflammation within the liver. A, B Hematoxylin and Eosin (H&E) staining shows no detectable inflammation within the liver in young (3 months) or E, F aged (18 months) wild type mice. C, D H&E staining within the young A30P liver shows focal inflammation within the liver parenchyma that is progressive and much more prominent in the aged A30P liver (G, H). Bars = 20 µmCC BY · PubMed Central
Fig. 7 Accumulation of human α-syn within the liver promotes inflammation in the A30P mouse model of PD. A–D Confocal image analysis on aged A30P liver sections demonstrate the presence of CD45-positve leukocytes, E–H CD11b-positive monocytes and I–L F4/80-positive Kupffer cells next to or in close proximity to α-syn deposits. M–P Partial co-localization between α-syn and the GFAP-positive perisinusoidal cells within the sinusoidal region. All tissue sections were counterstained with DAPI (blue). Bars = 20 µm
Fig. 7 Accumulation of human α-syn within the liver promotes inflammation in the A30P mouse model of PD. A–D Confocal image analysis on aged A30P liver sections demonstrate the presence of CD45-positve leukocytes, E–H CD11b-positive monocytes and I–L F4/80-positive Kupffer cells next to or in close proximity to α-syn deposits. M–P Partial co-localization between α-syn and the GFAP-positive perisinusoidal cells within the sinusoidal region. All tissue sections were counterstained with DAPI (blue). Bars = 20 µmCC BY · PubMed Central
Fig. 8 Accumulation of human α-syn within the human liver. A–C Confocal image analysis on human liver tissue sections immunolabeled with the 14H human-specific antibody (red) and anti-hepatocyte antibody (Hep, green) demonstrates the presence of human α-syn deposits within the sinusoidal regions, D–F portal tracts, and liver parenchyma (G–L) in PD and age-matched controls. Note that α-syn within liver hepatocytes appear as round puncta and often near nuclei. Importantly, not all hepatocytes within the affected region contain α-syn deposition. All tissue sections were counterstained with DAPI (blue). Bars = 20 µm
Fig. 8 Accumulation of human α-syn within the human liver. A–C Confocal image analysis on human liver tissue sections immunolabeled with the 14H human-specific antibody (red) and anti-hepatocyte antibody (Hep, green) demonstrates the presence of human α-syn deposits within the sinusoidal regions, D–F portal tracts, and liver parenchyma (G–L) in PD and age-matched controls. Note that α-syn within liver hepatocytes appear as round puncta and often near nuclei. Importantly, not all hepatocytes within the affected region contain α-syn deposition. All tissue sections were counterstained with DAPI (blue). Bars = 20 µmCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 74 references

Cited by

See all 61

Metadata

Authors
Reyes, J. F., Ekmark-Léwen, S., Perdiki, M., Klingstedt, T., Hoffmann, A., Wiechec, E., Nilsson, P., Nilsson, K. P. R., Alafuzoff, I., Ingelsson, M., & Hallbeck, M.
Affiliations
  • Linköping University (SE)
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Karolinska Institutet (SE)
  • Uppsala University Hospital (SE)
  • Uppsala University (SE)
Corresponding author
Reyes, Juan F.
Venue
Acta Neuropathologica Communications
Published
2021-03-20
Volume
9
Issue
1
Pages
46-46
ISSN
2051-5960 (ISSN-L)
OpenAlex
W3137660980
Cited by
59
References
74
Citations by year
2026: 15 · 2025: 22 · 2024: 9 · 2023: 9 · 2022: 2 · 2021: 2
FWCI
2.63
Type
journal article
Language
en
Open access
Licence
Locations
  • Acta Neuropathologica Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DiVA (Linkoping University) (submittedVersion, other-oa)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion, cc-by)
Funders
  • Vetenskapsrådet (2019-01016)
  • Linköping University
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
alpha-synuclein, Parkinson's disease, synucleinopathies, liver, hepatocytes, connexin 32, gap junctions, protein clearance, transgenic mouse model, amyloid-beta, protein oligomers
MeSH terms
Synucleinopathies, Aged, Aged, 80 and over, Animals, Brain, Disease Models, Animal, Female, Humans, Liver, Male, Mice, Transgenic, Parkinson Disease, Lewy Body Disease, Microscopy, Electron, Transmission, Mice, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease. https://app.cochat.ai/papers/10.1186/s40478-021-01136-3
The paper
Reyes, J. F., Ekmark-Léwen, S., Perdiki, M., Klingstedt, T., Hoffmann, A., Wiechec, E., Nilsson, P., Nilsson, K. P. R., Alafuzoff, I., Ingelsson, M., & Hallbeck, M. (2021). Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-021-01136-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.